SLC5A2 and diabetic kidney disease: Beyond the hemodynamic effect, reduced glucose uptake through the proximal tubular cells by SGLT2 inhibition alleviates DKD by inhibiting hyperglycemia-related tubulointerstitial injury (Anders et al., 2018; Kalantar-Zadeh et al., 2021).